The cell of origin in Hodgkin's disease

CDK4/6 inhibition in advanced chordoma: final results of the NCT PMO-1601 trial.

ESMO open·2025

Drug monitoring detects under- and overdosing in patients receiving 5-fluorouracil-containing chemotherapy-results of a prospective, multicenter German observational study.

ESMO open·2023

Comprehensive cancer predisposition testing within the prospective MASTER trial identifies hereditary cancer patients and supports treatment decisions for rare cancers.

Annals of oncology : official journal of the European Society for Medical Oncology·2022

Assessment of the management of carcinomatous meningitis from breast cancer globally: a study by the Breast International Group Brain Metastasis Task Force.

ESMO open·2022

Long-term health sequelae and quality of life at least 6 months after infection with SARS-CoV-2: design and rationale of the COVIDOM-study as part of the NAPKON population-based cohort platform (POP).

Infection·2021

A randomised phase II study investigating durvalumab in addition to an anthracycline taxane-based neoadjuvant therapy in early triple-negative breast cancer: clinical results and biomarker analysis of GeparNuevo study.

Annals of oncology : official journal of the European Society for Medical Oncology·2019

Integrating patient-reported outcomes into explainable machine learning models for long-term survival prediction in TKI-treated metastatic renal cell carcinoma.

Seminars in oncology·2026

Tumour immunotherapy in solid and hematologic malignancies: Progress, challenges, and a practical framework.

Seminars in oncology·2026

Single-cell sequencing in pan-cancer research: Decoding heterogeneity, tumor microenvironment, and clinical translation.

Seminars in oncology·2026

Atezolizumab, lurbinectedin, tarlatamab, and FOLFIRNOX in a patient with metastatic small cell carcinoma of the anal canal: A case report and review of the literature.

Seminars in oncology·2026

Uncovering an uncommon diagnosis: Encapsulated papillary carcinoma of the male breast in a Jordanian patient-A case report.

Seminars in oncology·2026

Silver nanoparticles in tumor microenvironment modulation: Mechanistic insights, preclinical evidence, and translational challenges.

Seminars in oncology·2026

The Shared IL-12/IL-35 p35 Subunit Is Associated With Heightened Atherogenic Risk in African Patients With Type 2 Diabetes.

Endocrinology, diabetes & metabolism·2026

Updates on the Evaluation of Lupus Arthritis.

Rheumatology and therapy·2026

SDH inhibition quenches rheumatoid arthritis flare-associated IL-1β+IFN-γ+ macrophages via NF-κB/STAT4.

Annals of the rheumatic diseases·2026

Rapidly progressive glomerulonephritis in rheumatoid arthritis: an early presentation of ANCA-associated vasculitis.

BMJ case reports·2026

Autoimmune hepatitis: special groups and treatment gaps.

JHEP reports : innovation in hepatology·2026

Synovial short-lived plasma cells mediate adalimumab resistance in rheumatoid arthritis via MIF-CD74 axis-driven, partially TNF-α-independent inflammation.

Journal of autoimmunity·2026

Related Experiment Videos

The cell of origin in Hodgkin's disease

Related Concept Videos

CDK4/6 inhibition in advanced chordoma: final results of the NCT PMO-1601 trial.

Drug monitoring detects under- and overdosing in patients receiving 5-fluorouracil-containing chemotherapy-results of a prospective, multicenter German observational study.

Comprehensive cancer predisposition testing within the prospective MASTER trial identifies hereditary cancer patients and supports treatment decisions for rare cancers.

Assessment of the management of carcinomatous meningitis from breast cancer globally: a study by the Breast International Group Brain Metastasis Task Force.

Long-term health sequelae and quality of life at least 6 months after infection with SARS-CoV-2: design and rationale of the COVIDOM-study as part of the NAPKON population-based cohort platform (POP).

A randomised phase II study investigating durvalumab in addition to an anthracycline taxane-based neoadjuvant therapy in early triple-negative breast cancer: clinical results and biomarker analysis of GeparNuevo study.

Integrating patient-reported outcomes into explainable machine learning models for long-term survival prediction in TKI-treated metastatic renal cell carcinoma.

Tumour immunotherapy in solid and hematologic malignancies: Progress, challenges, and a practical framework.

Single-cell sequencing in pan-cancer research: Decoding heterogeneity, tumor microenvironment, and clinical translation.

Atezolizumab, lurbinectedin, tarlatamab, and FOLFIRNOX in a patient with metastatic small cell carcinoma of the anal canal: A case report and review of the literature.

Uncovering an uncommon diagnosis: Encapsulated papillary carcinoma of the male breast in a Jordanian patient-A case report.

Silver nanoparticles in tumor microenvironment modulation: Mechanistic insights, preclinical evidence, and translational challenges.

The Shared IL-12/IL-35 p35 Subunit Is Associated With Heightened Atherogenic Risk in African Patients With Type 2 Diabetes.

Updates on the Evaluation of Lupus Arthritis.

SDH inhibition quenches rheumatoid arthritis flare-associated IL-1β+IFN-γ+ macrophages via NF-κB/STAT4.

Rapidly progressive glomerulonephritis in rheumatoid arthritis: an early presentation of ANCA-associated vasculitis.

Autoimmune hepatitis: special groups and treatment gaps.

Synovial short-lived plasma cells mediate adalimumab resistance in rheumatoid arthritis via MIF-CD74 axis-driven, partially TNF-α-independent inflammation.

Related Experiment Videos

The cell of origin in Hodgkin's disease

Related Concept Videos

Related Articles